Antibody Drug Discovery
Driving Innovation in Antibody Therapeutics
Antibody-based drugs have become a cornerstone of modern targeted therapies, addressing cancer, autoimmune diseases, infectious diseases, and more. The development process demands precise sequence identification, gene synthesis, and efficient recombinant antibody production. High-quality raw materials and rapid turnaround are essential to accelerate discovery and optimize candidates.
GenCefe Biotech offers integrated solutions to support your antibody drug development pipeline—from NGS sequencing of antibody repertoires, through gene synthesis and vector construction, to recombinant antibody expression and purification.
Application Scenarios in Antibody Drug Development:
Application Area | User Needs | GenCefe Solutions |
Therapeutic Antibody Discovery and Optimization | Precisely identify and optimize antibody sequences to improve affinity, specificity, and stability for rapid candidate screening. | - High-throughput NGS sequencing for antibody libraries and single-cell clones |
Antibody Expression and Production for Preclinical Studies | Efficient expression and purification of monoclonal antibodies, fragments, and engineered antibodies for in vitro and in vivo studies. | - Mammalian and cell-free protein expression platforms |
Bispecific and Engineered Antibody Development | Design and construct bispecific antibodies, antibody fusion proteins, and complex molecular formats to enhance therapeutic efficacy. | - Complex gene synthesis and multi-gene vector construction |
Biomarker and Diagnostic Antibody Development | Generate highly specific antibodies for diagnostic assays, supporting biomarker discovery and validation in preclinical settings. | - NGS-based antibody origin sequencing and optimization |
Antibody Engineering and Affinity Maturation | Enhance antibody properties through targeted or random mutagenesis and rapidly screen high-affinity variants. | - Design and synthesis of mutagenesis libraries |
GenCefe Core Service Modules | Supporting Antibody Drug Discovery
· Next-Generation Sequencing (NGS): Deep sequencing for antibody repertoires, library characterization, and clone verification.
· Gene Synthesis: High-accuracy synthesis of antibody genes optimized for mammalian or other expression systems.
· Plasmid Construction: Vector cloning for antibody expression, including multi-gene constructs and tag fusions.
· Protein Expression & Purification: Recombinant antibody production in mammalian, insect, or cell-free systems with purification options.
· Mutagenesis and Library Construction: Targeted or random mutation libraries for antibody engineering and affinity optimization.
